{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 248,
  "pageCount": 415,
  "prevPage": 247,
  "nextPage": 249,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A transcript format to highlight potential safety concerns and lack of transparency regarding trial outcomes.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/248",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-248",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The KOL stated that these two cases of diabetes – on a relatively small trial size – are under-the-radar and seemed to hint at pressure to stay silent, perhaps from a patient association or Soleno – “...and they’ve been told, like they’re pretty quiet about it...FYI, they don’t really feel comfortable telling other people about it because they don’t want to scare anybody.”",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ac-8c2b50f0e8b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Two patients in their early 20’s allegedly developed diabetes shortly after starting Vykat; still uncontrolled several years later; Q: “And you know this because you’ve spoken with the families?” A: “Mm-hmm. And they’ve been told, like they’re pretty quiet about it. FYI, they don’t feel really comfortable telling other people about it because they don’t want to scare anybody. Just this idea that they feel uncomfortable in the community talking about it.” Q: “And were they obese — I get all these kids are at risk for diabetes.” A: “Sure. Just a little something. If you look at them on the street, they would not stand out as somebody who was obese. I would say slightly overweight for both of them.” – KOL in the PWS field; involved with Soleno’s clinical program",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd59978e-baa2-409f-add6-d2fa88843813",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“...and they’ve been told, like they’re pretty quiet about it. FYI, they don’t really feel comfortable telling other people about it because they don’t want to scare anybody.” — KOL in the PWS field; involved with Soleno’s clinical program",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ac-9341be3741f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "655d2974-4175-4a57-9fda-8b02a022a604",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The KOL stated that these two cases of diabetes – on a relatively small trial size – are under-the-radar and seemed to hint at pressure to stay silent, perhaps from a patient association or Soleno – “...and they’ve been told, like they’re pretty quiet about it...FYI, they don’t really feel comfortable telling other people about it because they don’t want to scare anybody.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "caf8bc6d-e480-44a5-95bc-ffece2acf2cc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "70d33a1f-40a2-4e8f-b0af-c18ff58e5c86",
      "evidence": "The slide uses expert testimony to expose potential suppression of adverse clinical trial events.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}